This Hedge Fund Insight unpacks the rise of a new class of drugs that target obesity as a chronic disease and presents significant investable opportunities before 2031.
Where Australian Family Groups Come For Clear Insights, To Make Money In All Market Conditions And To Protect Their Wealth.
Where Australian Family Groups Come For Clear Insights, To Make Money In All Market Conditions And To Protect Their Wealth.
© 2025 Australian Standfirst Asset Management Pty Ltd ACN 612 265 219 as an AFS Representative 1276948 of Australian Standfirst Funds Management Ltd ACN 618 083 079 AFSL 510315.